| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Incyte Corporation's insiders have reduced their positions by a net 124,153 shares worth roughly $15.0M. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
The insider who sold still holds shares after the sale. Classified under Health Care Equipment & Supplies (Health Care sector), INCY's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 28.21M | - | - | |
| Dir | 326.8K | $31.60M | - | |
| Pres | 183.2K | $20.65M | -2,642 | |
| CEO | 183.1K | - | - | |
| VP | 71.8K | $8.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sale+OE10b5-1 | 2,642 | $112.71 | $297,779.82 | -1.4% | - | - | |
| Sep 15, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sale+OE10b5-1 | 23,218 | $120.49 | $2,797,629.15 | -11.2% | - | - | |
| Aug 19, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sell10b5-1 | 10,801 | $125.56 | $1,356,173.56 | -5.6% | - | - | |
| Aug 12, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sell10b5-1 | 10,803 | $120.04 | $1,296,792.12 | -5.3% | - | - | |
| Aug 5, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sell10b5-1 | 10,640 | $122.69 | $1,305,421.60 | -4.9% | - | - | |
| Aug 5, 2026 | Mayes Patrick A | EVP &Chief Scientific Officer | Sale+OE10b5-1 | 2,207 | $123.99 | $273,645.93 | -3.5% | - | - | |
| Aug 3, 2026 | Mayes Patrick A | EVP &Chief Scientific Officer | Sale+OE10b5-1 | 47,954 | $119.58 | $5,734,376.33 | -43.8% | - | - | |
| Jul 31, 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sell10b5-1 | 15,888 | $119.70 | $1,901,793.60 | -6.9% | - | - | |
| Jul 16, 2026 | Stein Steven H51 | CMO &Head of Late-stage Dev. | Sell10b5-1 | 1,877 | $114.73 | $215,348.21 | -8.2% | -4.4% | - | |
| Jul 16, 2026 | Issa Mohamed Khairie | EVP, Head of U.s. Commercial | Sell10b5-1 | 1,093 | $115.01 | $125,705.93 | -1.7% | -4.4% | - |